AtheroTalk

E30: Magdalena Daccord

37 min · 7. huhti 2026
jakson E30: Magdalena Daccord kansikuva

Kuvaus

This interview features Magdalena Daccord, CEO of FH Europe Foundation, discussing key challenges and future directions in the management of familial hypercholesterolemia (FH). The conversation focuses on patient advocacy, early diagnosis, and the importance of international collaboration between clinicians, researchers, and policymakers. Special attention is given to emerging initiatives, including the Lp(a) International Task Force, and the role of patient networks in improving awareness and access to care. --------------------------------------------------- Script-prep: Maria Cherska, Azin Kheirkhah, Svetlana Stoica Interviewer: Maria Cherska, Svetlana Stoica

Kommentit

0

Ole ensimmäinen kommentoija

Rekisteröidy nyt ja liity AtheroTalk-yhteisöön!

Aloita nyt

3 kuukautta hintaan 7,99 €

Sitten 7,99 € / kuukausi · Peru milloin tahansa.

  • Podimon podcastit
  • 20 kuunteluaikaa / kuukausi
  • Lataa offline-käyttöön

Kaikki jaksot

33 jaksot

jakson E32: Pablo Corral kansikuva

E32: Pablo Corral

What does it take to build a career at the intersection of clinical care, research, and global collaboration? In this episode of AtheroTalk, we speak with Prof. Pablo Corral from Argentina, who brings a grounded and insightful perspective on lipid disorders, cardiovascular prevention, and the evolving role of large-scale clinical trials. From tackling familial hypercholesterolemia to addressing residual risk, he shares both the realities and possibilities of advancing care in Latin America. Along the way, he reflects on mentorship, career choices, and what truly sustains long-term motivation, captured in one simple idea: “Find something you are truly passionate about.” A thoughtful conversation for anyone navigating science, medicine, and purpose. --------------------------------------------------- Script-prep: Pelin Golforoush Interviewer: Pelin Golforoush

5. touko 202627 min
jakson E29: John J.P. Kastelein kansikuva

E29: John J.P. Kastelein

In this episode of AtheroTalk, we are honored to host Prof. John J.P. Kastelein, one of the most influential figures in lipidology and cardiovascular prevention. With a career spanning decades of groundbreaking research and innovation, Prof. Kastelein shares his personal journey and reflects on the evolution of lipid-lowering therapy — from the early days of statins to today’s rapidly expanding pipeline of novel therapeutics. Together, we explore the milestones that have shaped modern cardiovascular prevention, the lessons learned along the way, and the exciting future of precision lipid management. This conversation offers unique insights into the intersection of science, clinical practice, and drug development, from someone who has been at the forefront of it all. --------------------------------------------------- Script-prep: Fotis Barkas Interviewer: Fotis Barkas

19. maalis 202636 min